Progenesis is a San Diego-based company founded in 2015 that develops and offers non-invasive genetic tests for patients on their family planning journey. We offer a variety of services that can be customized to meet the needs of every patient we serve. The Progenesis team is a motivated group of genetic specialists, researchers, laboratory professionals, and analysts who are passionate about improving our patients’ lives. As pioneers in genetic screening technologies, our scientists are constantly pursuing research initiatives to advance our services and expand our understanding of human genetics.
Our patients entrust us with the longevity of their future children, and we take this responsibility to heart. All of our tests utilize the latest industry-leading molecular biology techniques to deliver our patients with the most accurate results that current technology offers. Our team has optimized Next Generation sequencing for 24-chromosome aneuploidy (PGS) and provides a 12-hour PGS test for fresh transfers.
In the lab, we hold ourselves to the highest standards of quality control and assurance. We are accredited by the College of American Pathologists (CAP) and certified through Clinical Laboratory Improvement Amendments (CLIA#05D2121237). Our customer support team works closely with IVF clinics to ensure patient information is shared securely and efficiently. We are dedicated to consistently delivering high quality services. Genetic counselors on our staff are always available to answer questions at all stages of family planning.
About Dr. Arrach:
Dr. Nabil Arrach has 20 years of research experience in molecular genetics, both in preclinical and clinical settings. He has worked at several prestigious research centers, including the University of California, Berkeley, Sanford-Burnham Medical Research Institute and the University of California, Irvine, and has numerous high impact publications and a successful record in grant funding. Dr. Arrach is the co-founder of Progenesis located in La Jolla, CA, the world leader in next generation sequencing technology for embryo testing. Dr. Arrach was the first scientist to optimize and validate next generation sequencing for PGS and PGD. He continues to work on new emerging fields in IVF including spent media testing. Dr. Arrach holds a Ph.D. in Molecular and Cellular Biology. Under Dr. Arrach’s guidance, Progenesis stands at the forefront of NGS research technology; it is the only company to offer PGD using next generation sequencing.
“Next Generation Sequencing technology is a fast moving field in medicine, and reproductive medicine in particular. My interest is to develop and utilize cutting edge technology to further our understanding of embryo development. My goal is to improve the detection of genetic conditions in embryos, while optimizing the implantation and pregnancy rate.” -Dr. Nabil Arrach, Ph.D, MBA